Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
Arzu Yaşar H, Turna H, Esin E, Murat Sedef A, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akbulut H, Celik I, Abalı H, Urun Y.
Arzu Yaşar H, et al. Among authors: murat sedef a.
J Oncol Pharm Pract. 2020 Mar;26(2):267-272. doi: 10.1177/1078155219840796. Epub 2019 Mar 29.
J Oncol Pharm Pract. 2020.
PMID: 30924738